Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have higher oxidative stress and hormone imbalances, suggesting managing oxidative stress could help.

Androgen levels do not determine the type of PCOS symptoms in young females.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

Androgens can both promote and prevent hair growth due to differences in gene expression in hair follicles.

Finasteride effectively reduces hair loss by decreasing androgen levels.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Reduced AR gene methylation may cause early pubic hair growth in girls.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

New finasteride solution effectively reduces baldness-causing hormone, potentially with fewer side effects.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Hidradenitis suppurativa improves with antiandrogen therapy.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Male rats have androgen receptors in their liver, which are different from proteins that bind estrogen.

AR gene not major factor in female hair loss; different from male hair loss.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Scientists made all eight versions of a compound called cyoctol, but found it's not an anti-androgen and it fully breaks down in the skin.